Skip to main content
Clinical Trials/NCT06000540
NCT06000540
Not Yet Recruiting
N/A

A Prospective Pilot Study to Evaluate the Safety, Tolerability and Efficacy of Utilizing Precise Computer Controlled Gas Challenge in Healthy Subjects for Identification of Coronary Artery Disease

Indiana University1 site in 1 country80 target enrollmentJanuary 10, 2026

Overview

Phase
N/A
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Indiana University
Enrollment
80
Locations
1
Primary Endpoint
Assessment of Symptom Severity and Incidence
Status
Not Yet Recruiting
Last Updated
8 months ago

Overview

Brief Summary

This is a prospective pilot study to evaluate the safety, tolerability and efficacy of utilizing precise computer controlled gas challenge in healthy subjects for identification of coronary artery disease.

Detailed Description

This study will establish the safe and tolerable level of high PC02 and low P02 for future studies as potential stressors for coronary artery disease assessment.

Registry
clinicaltrials.gov
Start Date
January 10, 2026
End Date
June 15, 2027
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rohan Dharmakumar

Executive Director, Krannert Cardiovascular Research Center

Indiana University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Adults ≥ 45 years of age
  • No known cardiac disease

Exclusion Criteria

  • Low blood pressure (systolic blood pressure \< 100 mmHg)
  • Inability to voluntarily increase their breathing rate if prompted to do so
  • Persons with the inability to lie supine for 30-40 minutes
  • Persons who are pregnant, nursing, or implanted with intrauterine devices (IUD's)
  • Persons with significant neurological, pulmonary, renal or hepatic disease
  • Persons who have an abnormal cardiac rhythm or resting heart rate \>100/min
  • Inability or unwillingness to provide informed consent

Outcomes

Primary Outcomes

Assessment of Symptom Severity and Incidence

Time Frame: 3 hours

1. Chest pain 2. Headache 3. Dizziness 4. Confusion 5. Fatigue 6. Upset stomach 7. Nausea 8. Vomiting

Physiological Parameters Monitoring

Time Frame: 3 hours

1. Saturation of peripheral oxygen as percentage 2. Heart rate as beats per minute 3. Noninvasive blood pressure as mmHg 4. Partial pressure of oxygen as mmHg 5. Partial pressure of carbon dioxide as mmHg

Secondary Outcomes

  • Participant Completion(Day 1 and Day 2)
  • Patient comfort level score(3 hours)
  • Quality of Cardiac MRI(3 hours)

Study Sites (1)

Loading locations...

Similar Trials